Activated Naïve B lymphocytes in SLE patients are capable of upregulating T-cell costimulatory molecules, and also endorse CD4+ cell proliferation and polarization to Th2 and Th17 cells. This evidence concerns the gene CD4 and systemic lupus erythematosus.